Changes in hypothalamic neurotransmitter and prostanoid levels in response to NMDA, CRF, and GLP-1 stimulation

Determination of neuroactive substances, such as neurotransmitters and prostanoids, in the extracellular space of the living brain is a very important technique in neuroscience. The hypothalamic paraventricular nucleus (PVN) is one of the most important autonomic control centers in the brain. Recently, we demonstrated that thromboxane (Tx) A(2) in the PVN may play an important role in adrenomedullary outflow evoked by N-methyl-d-aspartate (NMDA), corticotrophin-releasing factor (CRF), and glucagon-like peptide-1 (GLP-1) stimulation using microdialysis sampling and liquid chromatography-ion trap tandem mass spectrometry (LC-ITMSn). In the present study, we investigated whether centrally administered NMDA, CRF, and GLP-1 can release five neurotransmitters, acetylcholine (ACh), histamine, glutamate (Glu), gamma-aminobutyric acid (GABA), and serotonin (5-HT), along with six prostanoids, TxB(2), prostaglandin (PG) E-2, PGD(2), 15-deoxy-a dagger(12,14) (15d)-PGJ(2), 6-keto-PGF(1 alpha), and PGF(2 alpha) in rat PVN microdialysates after optimization of LC-ITMSn conditions . All stimulations increased the levels of 5-HT, TxB(2), PGE(2), and PGF(2 alpha) (except for 5-HT stimulated with GLP-1). Only NMDA increased the levels of ACh, Glu, and GABA. Treatment with dizocilpine maleate (MK-801), a noncompetitive NMDA receptor antagonist, attenuated the NMDA-induced increase in the levels of neuroactive substances except for Glu. This is the first study to use LC-ITMSn to analyze neurotransmitters and prostanoids in the same microdialysates from rat PVN.